ASO Author Reflections: Precision Immunoprofiling of the Tumor Microenvironment Predicts Recurrence in Advanced Colorectal Cancer.

Letizia Todeschini, Sophia Hernandez, Ajay V Maker

Abstract read

In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Letizia TodeschiniDivision of Surgical Oncology, Department of Surgery, University of California, San Francisco, CA, USA.

Sophia HernandezDivision of Surgical Oncology, Department of Surgery, University of California, San Francisco, CA, USA.

Ajay V MakerDivision of Surgical Oncology, Department of Surgery, University of California, San Francisco, CA, USA. ajay.maker@ucsf.edu.

Funding

Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer MetastasesR37CA238435 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Ajay V. Maker · 2020 to 2026

$2.5M

CLC NIH HHS BakerCLC NIH HHS DoD HT94252310674CLC NIH HHS DoD W81XWH-19-1-0457CLC NIH HHS NIH/NCI R37CA238435CLC NIH HHS Shorenstein Family FoundationCLC NIH HHS Simpson FNCI NIH HHS R37 CA238435

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40526346

DOI10.1245/s10434-025-17728-5

PMCPMC12602063

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.